COMPOSITION COMPRISING NEOAGAROOLIGOSACCHARIDE AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK

• 1. 新的联苯化合物或其可药用盐,用于制备所述新的联苯化合物或其可药用盐的方法,以及用于预防或治疗糖尿病并发症的包含其作为活性成分的药物组合物 [P] . 中国专利： CN103228602A . 2013-07-31
• 2. 新的喹啉酮衍生物和包含所述喹啉酮衍生物作为活性成分用于预防或治疗变应性疾病例如哮喘或特应性的药物组合物 [P] . 中国专利： CN110177796A . 2019-08-27
• 3. Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock [P] . 美国专利： US10548916B2 . 2020-02-04

  机译： 包含新琼脂寡糖作为有效成分的组合物，用于预防或治疗败血症或败血性休克

• 4. COMPOSITION COMPRISING NEOAGAROOLIGOSACCHARIDE AS ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK [P] . 美国专利： US2019290678A1 . 2019-09-26

  机译： 包含新葡糖寡糖的活性成分的组合物，用于预防或治疗脓毒症或败血症

• 5. Composition Comprising Neoagarooligosaccharide As Active Ingredient, For Prevention or Treatment of Sepsis or Septic Shock [P] . 美国专利： US2018055872A1 . 2018-03-01

  机译： 包含新琼脂寡糖作为有效成分的组合物，用于预防或治疗败血症或败血性休克

• 1. Raoultella planticolaBacteremia-Induced Fatal Septic Shock and Sepsis-Induced Coagulopathy in a Patient with Pancreatic Cancer: A Case Report and Literature Review [J] . Konul Hajiyeva, Mehmet Oral 临床医学国际期刊（英文） . 2021,第001期
• 2. Outcomes of severe sepsis and septic shock patients after stratifi cation by initial lactate value [J] . Kimberly A. Chambers, Adam Y. Park, Rosa C. Banuelos, 世界急诊医学杂志(英文版) . 2018,第002期
• 3. Neoagarooligosaccharides prevent septic shock by modulating A20-and cyclooxygenase-2-mediated interleukin-10 secretion in a septic-shock mouse model [J] . Kang Da Rae, Yoon Gun Young, Cho Joon, Biochemical and Biophysical Research Communications . 2017,第4期
• 4. Statins in prevention and treatment of severe sepsis and septic shock. [J] . Kouroumichakis I, Papanas N, Proikaki S, European journal of internal medicine . 2011,第2期
• 5. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J] . Shankar-Hari Manu, Phillips Gary S., Levy Mitchell L., JAMA: the Journal of the American Medical Association . 2016,第8期
• 6. SEPSIS SEPTIC SHOCK: RECOGNITION TREATMENT [C] . Armelle de Laforcade Annual Meeting of the American Animal Hospital Association . 2006
• 7. Integration of Recognition, Diagnostic, and Treatment Strategies between Prehospital Emergency Medical Services and Hospital Emergency Departments in the Management of Patients with Acute Sepsis and Septic Shock [D] . Duguay, Darren Caine. 2019
• 8. Early Infectious Disease Consultation Is Associated With Lower Mortality in Patients With Severe Sepsis or Septic Shock Who Complete the 3-Hour Sepsis Treatment Bundle [O] . Theresa Madaline, Francis Wadskier Montagne, Ruth Eisenberg, 2019
• 9. Clinical pathway intervention compliance and effectiveness when used in the treatment of patients with severe sepsis and septic shock at an Intensive Care Unit in Spain Cumplimiento y efectividad de las intervenciones de un protocolo clínico utilizado en pacientes con sepsis grave y shock séptico en una Unidad de Cuidados Intensivos en España Observância e efetividade das intervenções de um protocolo clínico utilizado para pacientes com sepse grave e choque séptico de uma Unidade de Cuidados Intensivos da Espanha [O] . Ana Laguna-Pérez, Elisa Chilet-Rosell, Miguel Delgado Lacosta, 2012

• 1. Precision medicine in sepsis and septic shock:From omics to clinical tools [J] . Juan Carlos Ruiz-Rodriguez ,Erika P Plata-Menchaca ,Luis Chiscano-Camón . 世界重症医学杂志 . 2022,第1期
• 2. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb®) in patients with sepsis and septic shock [J] . Rajib Paul ,Prachee Sathe ,Senthil Kumar . 世界重症医学杂志 . 2021,第001期
• 3. Machine learning in data abstraction: A computable phenotype for sepsis and septic shock diagnosis in the intensive care unit [J] . Prabij Dhungana ,Laura Piccolo Serafim ,Arnaldo Lopez Ruiz . 世界重症医学杂志 . 2019,第007期
• 4. 2012版严重脓毒症与脓毒性休克治疗国际指南 [C] . 钱素云 . 第六届首都急危重症医学高峰论坛 . 2013
• 5. 脓毒症及脓毒性休克维生素C治疗安全性及有效性-一项人、动物的系统评价及Meta分析 [A] . 韩利南 . 2019